Dr. Gladys Yee Duen Ng, MD, MPH

Dr. Ng practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Ng's NPI, 1164722450, was assigned on November 2, 2010. Dr. Ng graduated from Albany Medical College in 2008. Dr. Ng holds California license A112276.

Dr. Ng's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Ng's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Ng is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Ng to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ng practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ng's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ng is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ng's licenses on file in 2 states: California and Georgia.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney cysts, kidney removal surgery, kidney stone disease, pelvic prolapse and urinary endoscopy among the conditions Dr. Ng treats.

CMS data shows 566 Medicare services from Dr. Ng across 7 procedure codes in 2024, for 153 Medicare patients. Medicare paid $28,063 for them. Every service was in an office.

CMS counts 153 Medicare patients who saw Dr. Ng in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ng's median patient age at 45, with 37% women.

In 2024, Dr. Ng wrote 289 Medicare Part D claims for 91 patients. 69% of them were for generic drugs. CMS names the drug for 222 of them, across 7 drugs with 11 or more claims each, at $88,535 in total drug cost. In 2023, CMS named 431 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Ng for performance year 2024, reported as part of a group. Dr. Ng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ng as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Ng in 2022. 2022 was the busiest year, with 2. Dr. Ng's most frequent co-authors are Renea Michelle Sturm, MD and Sriram Venkata Eleswarapu, MD, PhD.

CMS Open Payments shows 56 general payments to Dr. Ng from 16 drug and device companies from 2016 to 2025. Grants make up the largest share, 43% of the total. Boston Scientific Corporation paid the most, $2,985.

Dr. Ng graduated from Albany Medical College in 2008.

Dr. Ng is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.